These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34418636)

  • 1. Does adjunctive hemoadsorption with CytoSorb affect survival of COVID-19 patients on ECMO? Authors' response.
    Supady A; Duerschmied D
    J Crit Care; 2021 Dec; 66():31-32. PubMed ID: 34418636
    [No Abstract]   [Full Text] [Related]  

  • 2. Does adjunctive hemoadsorption with CytoSorb affect survival of COVID-19 patients on ECMO? A critical statement.
    Köhler T; Schwier E; Henzler D; Eickmeyer C
    J Crit Care; 2021 Dec; 66():187-188. PubMed ID: 34330558
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply: Does adjunctive hemoadsorption with CytoSorb® affect survival of COVID-19 patients on ECMO? A critical statement.
    Putzu A; Schorer R
    J Crit Care; 2021 Dec; 66():189-190. PubMed ID: 34334278
    [No Abstract]   [Full Text] [Related]  

  • 4. Hemoadsorption in critically ill patients with or without COVID-19: A word of caution.
    Putzu A; Schorer R
    J Crit Care; 2021 Oct; 65():140-141. PubMed ID: 34148009
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of CytoSorb Hemoadsorption on Sedation Requirements in Patients With Severe COVID-19 on Venovenous Extracorporeal Membrane Oxygenation.
    Lewis TC; Merchan C; Toy B; Goldenberg RM; Geraci TC; Chang SH; Galloway AC; Smith DE; Moazami N
    ASAIO J; 2021 Aug; 67(8):856-861. PubMed ID: 34339400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reply to Supady et al. Comment on: Extracorporeal hemoadsorption in critically ill COVID-19 patients on VV ECMO: the CytoSorb therapy in COVID-19 (CTC) registry.
    Hayanga JWA
    Crit Care; 2023 Nov; 27(1):421. PubMed ID: 37919758
    [No Abstract]   [Full Text] [Related]  

  • 7. Adjuvant hemoadsorption therapy in patients with severe COVID-19 and related organ failure requiring CRRT or ECMO therapy: A case series.
    Wunderlich-Sperl F; Kautzky S; Pickem C; Hörmann C
    Int J Artif Organs; 2021 Oct; 44(10):694-702. PubMed ID: 34256643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemoadsorption treatment with CytoSorb
    Träger K; Skrabal C; Fischer G; Schroeder J; Marenski L; Liebold A; Reinelt H; Datzmann T
    Int J Artif Organs; 2020 Jun; 43(6):422-429. PubMed ID: 31868089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemoadsorption for management of patients on veno-venous ECMO support for severe COVID-19 acute respiratory distress syndrome.
    Geraci TC; Kon ZN; Moazami N; Chang SH; Carillo J; Chen S; Fargnoli A; Alimi M; Pass H; Galloway A; Smith DE
    J Card Surg; 2021 Nov; 36(11):4256-4264. PubMed ID: 34219277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival of Patients Treated With Extracorporeal Hemoadsorption and Extracorporeal Membrane Oxygenation: Results From a Nation-Wide Registry.
    Heidenreich A; Kaier K; Bode C; Zehender M; von Zur Mühlen C; Duerschmied D; Wengenmayer T; Stachon P; Supady A
    ASAIO J; 2023 Mar; 69(3):339-343. PubMed ID: 35857288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine Adsorption Therapy during Extracorporeal Membrane Oxygenation in Adult Patients with COVID-19.
    Rodeia SC; Martins FL; Fortuna P; Bento L
    Blood Purif; 2022; 51(9):791-798. PubMed ID: 34856539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of extracorporeal therapies in critically ill COVID-19 patients.
    Zhou Z; Kuang H; Ma Y; Zhang L
    J Zhejiang Univ Sci B; 2021 Sept 15; 22(9):701-717. PubMed ID: 34514751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opportunities, controversies, and challenges of extracorporeal hemoadsorption with CytoSorb during ECMO.
    Napp LC; Lebreton G; De Somer F; Supady A; Pappalardo F
    Artif Organs; 2021 Oct; 45(10):1240-1249. PubMed ID: 34152637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clindamycin clearance during Cytosorb
    Poli EC; Simoni C; André P; Buclin T; Longchamp D; Perez MH; Ferry T; Schneider AG
    Int J Artif Organs; 2019 May; 42(5):258-262. PubMed ID: 30819024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood purification therapy in patients with severe COVID-19 requiring veno-venous ECMO therapy: A retrospective study.
    Akil A; Ziegeler S; Rehers S; Ernst EC; Fischer S
    Int J Artif Organs; 2022 Jul; 45(7):615-622. PubMed ID: 35695200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 and Extracorporeal Membrane Oxygenation.
    Martucci G; Słomka A; Lebowitz SE; Raffa GM; Malvindi PG; Coco VL; Swol J; Żekanowska E; Lorusso R; Wierzba W; Suwalski P; Kowalewski M;
    Adv Exp Med Biol; 2021; 1353():173-195. PubMed ID: 35137374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined Use of CytoSorb and ECMO in Patients with Severe Pneumogenic Sepsis.
    Akil A; Ziegeler S; Reichelt J; Rehers S; Abdalla O; Semik M; Fischer S
    Thorac Cardiovasc Surg; 2021 Apr; 69(3):246-251. PubMed ID: 32252114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comment on: Extracorporeal hemoadsorption in critically ill COVID‑19 patients on VV ECMO: the CytoSorb therapy in COVID‑19 (CTC) registry.
    Supady A; Staudacher DL; Wengenmayer T
    Crit Care; 2023 Jul; 27(1):297. PubMed ID: 37488613
    [No Abstract]   [Full Text] [Related]  

  • 19. COVID-19: Hyperinflammatory Syndrome and Hemoadsorption with CytoSorb.
    Masmouei B; Harorani M; Bazrafshan MR; Karimi Z
    Blood Purif; 2021; 50(6):976-978. PubMed ID: 33326959
    [No Abstract]   [Full Text] [Related]  

  • 20. Persistent Right Ventricle Dilatation in SARS-CoV-2-Related Acute Respiratory Distress Syndrome on Extracorporeal Membrane Oxygenation Support.
    Lazzeri C; Bonizzoli M; Batacchi S; Cianchi G; Franci N; Socci F; Peris A
    J Cardiothorac Vasc Anesth; 2022 Jul; 36(7):1956-1961. PubMed ID: 34538743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.